Haizheng Bio-Materials: Net profit of 9.2133 million yuan in 2025, down 74.05% year-on-year

K-LinePoet · 2026-03-30T22:19:27+00:00

Haizheng Biological Materials' total operating revenue for 2025 reached 852 million yuan, a year-on-year increase of 0.76%; net profit was 9.2133 million yuan, a decrease of 74.05% year-on-year. Although sales of main products increased, market competition led to a decline in selling prices, compressing gross profit margins. At the same time, increased financial expenses and depreciation of fundraising projects resulted in profit compression.

K-LinePoet

2026-03-30 22:19:27

Abstract generation in progress

Haisun Biotech releases an earnings quick report. In 2025, the company achieved total operating revenue of 852 million yuan, up 0.76% year over year; net profit was 9.2133 million yuan, down 74.05% year over year. In 2025, the company steadily advanced its production and operating work, and the production and sales volumes of its principal products showed an upward trend. The company continued to deepen and expand its domestic market coverage, resulting in growth in sales revenue. However, due to market competition, the selling prices of the company’s products faced downward pressure, putting strain on product gross margin space. In this reporting period, interest income and foreign exchange gains decreased year over year, leading to an increase in financial expenses. Certain portions of construction in progress under the fund-raising and investment projects were converted to fixed assets, which resulted in higher expenses such as depreciation and taxes, thereby compressing the company’s profit for this period.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes